The fold of α-synuclein fibrils
暂无分享,去创建一个
Henning Stahlberg | Thorsten Lührs | Gerard Manning | Hui-Ting Chou | Roland Riek | R. Riek | G. Manning | H. Stahlberg | S. Maji | T. Lührs | Dominique Riek-Loher | M. Vilar | Marçal Vilar | H. Chou | Samir K Maji | Dominique Riek-Loher | Rene Verel | R. Verel | Thorsten Lührs
[1] K. Takegoshi,et al. Indirect high-resolution observation of 14N NMR in rotating solids. , 2001, Journal of the American Chemical Society.
[2] B. Meier,et al. Adiabatic dipolar recoupling in solid-state NMR: the DREAM scheme. , 2001, Journal of magnetic resonance.
[3] L. Serpell,et al. Synuclein proteins of the pufferfish Fugu rubripes: sequences and functional characterization. , 2006, Biochemistry.
[4] A. Brice,et al. Alpha-synuclein and Parkinson's disease , 2000, Cellular and Molecular Life Sciences CMLS.
[5] Makoto Hashimoto,et al. Transgenic models of alpha-synuclein pathology: past, present, and future. , 2003, Annals of the New York Academy of Sciences.
[6] P. Lansbury,et al. Accelerated Oligomerization by Parkinson's Disease Linked α‐Synuclein Mutants , 2000 .
[7] Michele Vendruscolo,et al. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.
[8] David Eisenberg,et al. Recent atomic models of amyloid fibril structure. , 2006, Current opinion in structural biology.
[9] C. Dobson,et al. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. , 2005, Journal of the American Chemical Society.
[10] Robert A. Grothe,et al. Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.
[11] Michel Goedert,et al. Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.
[12] J Q Trojanowski,et al. A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly* , 2001, The Journal of Biological Chemistry.
[13] M. Blackledge,et al. Defining long-range order and local disorder in native alpha-synuclein using residual dipolar couplings. , 2005, Journal of the American Chemical Society.
[14] Ted M. Dawson,et al. Animal Models of PD Pieces of the Same Puzzle? , 2002, Neuron.
[15] L. Regan,et al. A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy. , 2003, Biophysical journal.
[16] P. Lansbury,et al. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.
[17] P. Lansbury,et al. Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. , 2000, Annals of the New York Academy of Sciences.
[18] S. Becker,et al. Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Lindquist,et al. α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.
[20] Jeannie Chen,et al. Investigation of α-Synuclein Fibril Structure by Site-directed Spin Labeling* , 2007, Journal of Biological Chemistry.
[21] Sebastian Doniach,et al. Biophysical Properties of the Synucleins and Their Propensities to Fibrillate , 2002, The Journal of Biological Chemistry.
[22] B. Meier,et al. INADEQUATE-CR experiments in the solid state. , 1999, Journal of magnetic resonance.
[23] J. Gibrat,et al. GOR method for predicting protein secondary structure from amino acid sequence. , 1996, Methods in enzymology.
[24] T. Iwatsubo,et al. Biochemical characterization of the core structure of alpha-synuclein filaments. , 2002, The Journal of biological chemistry.
[25] B. Meier,et al. Adiabatic passage Hartmann-Hahn cross polarization in NMR under magic angle sample spinning , 1995 .
[26] E. Masliah,et al. beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. , 2001, Neuron.
[27] Thorsten Lührs,et al. Correlation of structural elements and infectivity of the HET-s prion , 2005, Nature.
[28] A Dürr,et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. , 2004, Lancet.
[29] D. Eliezer,et al. Conformational properties of alpha-synuclein in its free and lipid-associated states. , 2001, Journal of molecular biology.
[30] R. Riek,et al. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] Susan E Daniel,et al. Characterisation of isolated α-synuclein filaments from substantia nigra of Parkinson's disease brain , 2000, Neuroscience Letters.
[32] B. Meier,et al. Polarization-transfer methods in solid-state magic-angle-spinning NMR: adiabatic CN pulse sequences. , 2004, Chemphyschem : a European journal of chemical physics and physical chemistry.
[33] Gerd Buntkowsky,et al. Solid State NMR Reveals a pH-dependent Antiparallel β-Sheet Registry in Fibrils Formed by a β-Amyloid Peptide , 2004 .
[34] T. Nagatsu. [Biochemistry of Parkinson's disease]. , 1988, Seikagaku. The Journal of Japanese Biochemical Society.
[35] Seung-Jae Lee,et al. Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. , 2002, The Journal of biological chemistry.
[36] Gerd Krause,et al. General structural motifs of amyloid protofilaments , 2006, Proceedings of the National Academy of Sciences.
[37] M. Hoshino,et al. Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. , 2002, Nature structural biology.
[38] A. Linstedt. Faculty Opinions recommendation of Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. , 2006 .
[39] R. Crowther,et al. Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain. , 2000, Neuroscience letters.
[40] J. Trojanowski,et al. Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug Discovery , 2006, Neuron.
[41] Peter T Lansbury,et al. Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease. , 2003, Biochemistry.
[42] R. Riek,et al. 3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .
[43] Y. Yoo,et al. Orphan Nuclear Receptor Nur77 Translocates to Mitochondria in the Early Phase of Apoptosis Induced by Synthetic Chenodeoxycholic Acid Derivatives in Human Stomach Cancer Cell Line SNU‐1 , 2003, Annals of the New York Academy of Sciences.
[44] T. Iwatsubo,et al. Biochemical Characterization of the Core Structure of α-Synuclein Filaments* , 2002, The Journal of Biological Chemistry.
[45] J. George,et al. The synucleins , 2001, Genome Biology.
[46] Makoto Hashimoto,et al. β-Synuclein Inhibits α-Synuclein Aggregation A Possible Role as an Anti-Parkinsonian Factor , 2001, Neuron.
[47] David Eisenberg,et al. Structural models of amyloid-like fibrils. , 2006, Advances in protein chemistry.
[48] B. Meier,et al. Efficient N-15-C-13 polarization transfer by adiabatic-passage Hartmann-Hahn cross polarization , 1996 .
[49] L. Serpell,et al. Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[50] Makoto Hashimoto,et al. Transgenic Models of α‐Synuclein Pathology , 2003 .
[51] Ernst,et al. Spin diffusion in resolved solid-state NMR spectra. , 1985, Physical review. B, Condensed matter.
[52] V. Lee,et al. Alpha-synuclein: normal function and role in neurodegenerative diseases. , 2004, Current topics in developmental biology.
[53] Diego Guidolin,et al. α‐Synuclein and Parkinson's disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[54] V. Uversky,et al. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. , 2001, Biochemistry.
[55] A Dürr,et al. Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.
[56] Ralf Langen,et al. Structural Organization of α-Synuclein Fibrils Studied by Site-directed Spin Labeling* , 2003, Journal of Biological Chemistry.
[57] W. Bender,et al. A Drosophila model of Parkinson's disease , 2000, Nature.
[58] K. Iwata,et al. 3D structure of amyloid protofilaments of β2-microglobulin fragment probed by solid-state NMR , 2006, Proceedings of the National Academy of Sciences.
[59] Jeannie Chen,et al. Investigation of alpha-synuclein fibril structure by site-directed spin labeling. , 2007, The Journal of biological chemistry.
[60] B. Meier,et al. Methods for sequential resonance assignment in solid, uniformly 13C, 15N labelled peptides: Quantification and application to antamanide , 2001, Journal of biomolecular NMR.
[61] L. Golbe. Alpha-synuclein and Parkinson's disease. , 2003, Advances in neurology.
[62] Patrik Brundin,et al. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. , 2002, Nature reviews. Neuroscience.
[63] P. Lansbury,et al. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. , 2000, Biochemistry.